ALGS
Aligos Therapeutics Inc
NASDAQ: ALGS · HEALTHCARE · BIOTECHNOLOGY
$5.99
+0.34% today
Updated 2026-04-30
Market cap
$36.94M
P/E ratio
—
P/S ratio
16.90x
EPS (TTM)
$-2.45
Dividend yield
—
52W range
$4 – $14
Volume
0.2M
Aligos Therapeutics Inc (ALGS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-12,908.00%
ROE
-196.90%
ROA
-69.30%
Debt/equity
0.08x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $0.00 | $-13.93M | — | — | — |
| 2019 | $0.00 | $-52.26M | — | — | — |
| 2020 | $-10.55M | $-108.54M | 100.00% | 927.51% | 1,029.04% |
| 2021 | $4.36M | $-128.33M | 100.00% | -2,943.82% | -2,944.07% |
| 2022 | $13.91M | $-96.05M | 100.00% | -701.66% | -690.63% |
| 2023 | $15.53M | $-87.68M | 100.00% | -567.50% | -564.61% |
| 2024 | $3.94M | $-131.21M | 100.00% | -2,259.92% | -3,326.01% |
| 2025 | $2.19M | $-24.19M | 57.46% | -4,024.93% | -1,106.72% |